Go Pro
OTCMKTS:MEDIF

MediPharm Labs (MEDIF) Stock Price, News & Analysis

MediPharm Labs logo
$0.06 0.00 (-0.88%)
As of 10:05 AM Eastern

About MediPharm Labs Stock (OTCMKTS:MEDIF)

Advanced

Key Stats

Today's Range
$0.05
$0.06
50-Day Range
$0.05
$0.06
52-Week Range
$0.04
$0.08
Volume
849 shs
Average Volume
77,851 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products. MediPharm Labs also provides custom formulation and white-label manufacturing services to licensed producers and pharmaceutical partners, delivering turnkey solutions from initial concept through commercial production.

MediPharm Labs serves domestic clients across Canada’s provincial distribution networks and is advancing export opportunities in Europe and Latin America under evolving regulatory frameworks. Its operations emphasize consistent quality, rigorous testing, and strict adherence to international standards, positioning the company as a preferred partner for institutional and research-focused customers.

Founded in 2015 by Kully Saluja, who serves as President and CEO, MediPharm Labs has expanded its capacity through strategic investments in automation and analytics. The leadership team combines expertise in pharmaceutical manufacturing, regulatory compliance and cannabis science, guiding the company’s growth as it scales production and explores new markets.

AI Generated. May Contain Errors.

Receive MEDIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MEDIF Stock News Headlines

The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
MediPharm Labs Corp MEDIF
See More Headlines

MEDIF Stock Analysis - Frequently Asked Questions

MediPharm Labs' stock was trading at $0.0498 at the beginning of 2026. Since then, MEDIF shares have increased by 12.7% and is now trading at $0.0561.

Shares of MEDIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MEDIF
CIK
N/A
Fax
N/A
Employees
166
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (OTCMKTS:MEDIF) was last updated on 9/15/2026 by MarketBeat.com Staff.
From Our Partners